Aspirin can improve outcomes for patients undergoing heart surgery, a new study from Thomas Jefferson University and UC Davis has found.
Patients undergoing coronary artery bypass grafts or valve surgery were given aspirin at least once in a five day period before their surgery.
Compared with patients who did not receive pre-operative aspirin, there was a significant decrease in the risk of 30-day mortality and average time spent in intensive care. There were also decreases in the risk of major adverse cardio-cerebral events and renal failure.
Read more at Thomas Jefferson University and University of California, Davis